Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis

Germinal centers (GCs) can be observed in the thymic tissues of individuals with thymoma-associated myasthenia gravis (TAMG). This study aimed to investigate the association between the presence of GCs in the thymus and the clinical outcomes of patients with TAMG following thymoma resection. A retrospective review was conducted on patients diagnosed with TAMG who underwent surgical removal of the thymoma. Upon reviewing thymic tissue slides to determine the presence of GCs, patients were divided into GC-positive and GC-negative groups. The association between the presence of GCs and the achievement of minimal manifestation (MM) or pharmacological remission (PR) was analyzed after adjusting for clinical characteristics. Of the 111 patients, 41 (36.9%) with thymic follicular hyperplasia were classified into the GC-positive group, and the remaining patients were classified into the GC-negative group. Initial analyses including the entire patient cohort did not demonstrate a significant association between GC and achieving MM or PR post-thymectomy. However, a refined analysis that excluded patients treated with prednisolone before thymectomy revealed a significantly lower cumulative incidence of MM in the GC-positive group ( p = 0.011). The presence of GCs was negatively associated with achieving MM, even after adjusting for confounding variables (hazard ratio = 0.479, 95% confidence interval = 0.237–0.968, p = 0.040). Ectopic GCs in the thymus may serve as a prognostic factor for poor outcomes in patients with TAMG. Further research is needed to elucidate the role of GCs in the pathogenesis of TAMG and predict clinical outcomes following treatment. • Germinal centers (GCs) can be found in the non-thymomatous tissue of TAMG. • Patients with pre-op prednisolone use have a lower number of GCs. • In patients without pre-op prednisolone, GCs correlate with lower rates of MM. • Increasing number of GCs may indicate poor outcome in TAMG.

Authors

Institutions

Publication Details

Journal
Journal of Neuroimmunology
Published
2026-04-03
DOI
https://doi.org/10.1016/j.jneuroim.2026.578926
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis

Ha Young Shin, Hye Yoon Chung, Gi Jeong Kim, Seung Woo Kim et al.
Journal of Neuroimmunology
Myasthenia Gravis and Thymoma
article

Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis

Ha Young Shin, Hye Yoon Chung, Gi Jeong Kim, Seung Woo Kim, Hyung Jun Park
article en

Abstract

Germinal centers (GCs) can be observed in the thymic tissues of individuals with thymoma-associated myasthenia gravis (TAMG). This study aimed to investigate the association between the presence of GCs in the thymus and the clinical outcomes of patients with TAMG following thymoma resection. A retrospective review was conducted on patients diagnosed with TAMG who underwent surgical removal of the thymoma. Upon reviewing thymic tissue slides to determine the presence of GCs, patients were divided into GC-positive and GC-negative groups. The association between the presence of GCs and the achievement of minimal manifestation (MM) or pharmacological remission (PR) was analyzed after adjusting for clinical characteristics. Of the 111 patients, 41 (36.9%) with thymic follicular hyperplasia were classified into the GC-positive group, and the remaining patients were classified into the GC-negative group. Initial analyses including the entire patient cohort did not demonstrate a significant association between GC and achieving MM or PR post-thymectomy. However, a refined analysis that excluded patients treated with prednisolone before thymectomy revealed a significantly lower cumulative incidence of MM in the GC-positive group ( p = 0.011). The presence of GCs was negatively associated with achieving MM, even after adjusting for confounding variables (hazard ratio = 0.479, 95% confidence interval = 0.237–0.968, p = 0.040). Ectopic GCs in the thymus may serve as a prognostic factor for poor outcomes in patients with TAMG. Further research is needed to elucidate the role of GCs in the pathogenesis of TAMG and predict clinical outcomes following treatment. • Germinal centers (GCs) can be found in the non-thymomatous tissue of TAMG. • Patients with pre-op prednisolone use have a lower number of GCs. • In patients without pre-op prednisolone, GCs correlate with lower rates of MM. • Increasing number of GCs may indicate poor outcome in TAMG.

Journal of NeuroimmunologyVol. 417
Hallym University (KR), Yonsei University (KR), Severance Hospital (KR), University Health System (US), Gangnam Severance Hospital (KR), Yonsei University Health System (KR)
Yonsei University
No poverty
Openalex Percentile: Top 7%
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.